US 9,809,532 B2
Uses of histone acetyltransferase activators
Yitshak Francis, New York, NY (US); Ottavio Arancio, New York, NY (US); and Mauro Fa, New York, NY (US)
Assigned to THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, New York, NY (US)
Appl. No. 14/125,214
Filed by Yitshak Francis, New York, NY (US); Ottavio Arancio, New York, NY (US); and Mauro Fa, New York, NY (US)
PCT Filed Jun. 11, 2012, PCT No. PCT/US2012/041907
§ 371(c)(1), (2), (4) Date Aug. 12, 2014,
PCT Pub. No. WO2012/171008, PCT Pub. Date Dec. 13, 2012.
Claims priority of provisional application 61/495,495, filed on Jun. 10, 2011.
Prior Publication US 2014/0350116 A1, Nov. 27, 2014
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/167 (2006.01); C07C 237/44 (2006.01); A61P 25/00 (2006.01)
CPC C07C 237/44 (2013.01) [A61K 31/167 (2013.01)] 6 Claims
 
1. A method for treating memory loss or a learning disability in a subject in need thereof, which comprises administering to the subject a therapeutically effective amount of compound (I):

OG Complex Work Unit Drawing
or a pharmaceutically acceptable salt thereof, wherein the subject is not afflicted with a neurodegenerative condition or disease.